Rezolute (RZLT) Receivables - Other (2013 - 2023)

Rezolute (RZLT) reported Receivables - Other of $400000.0 for Q3 2023, up 33.33% sequentially from $300000.0 in Q2 2023.

Rezolute (RZLT) Receivables - Other (2013 - 2023) Analysis & Trends

Rezolute (RZLT) has 4 years of Receivables - Other data on file, last reported at $400000.0 in Q3 2023.

For the quarter ending Q3 2023, Receivables - Other changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Sep 2023 stood at $400000.0 (changed N/A YoY), and the FY2023 full-year result was $300000.0, changed N/A from the prior year.
Receivables - Other climbed to $400000.0 in Q3 2023, from $300000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $400000.0 in Q3 2023 to a low of $247000.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Rezolute	31,153.77	31,153.77	-

Download Data